| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 09/28/1994 | EP0616537A1 CDw52-SPECIFIC ANTIBODY FOR TREATMENT OF MULTIPLE SCLEROSIS |
| 09/28/1994 | EP0537267B1 Autobiotics and their use in eliminating nonself cells in vivo |
| 09/28/1994 | EP0528847B1 Soluble, truncated gamma-interferon receptors |
| 09/28/1994 | EP0506836B1 BCRF1 PROTEINS AS INHIBITORS OF INTERFERON-$g(g) |
| 09/28/1994 | EP0489732B1 A uv-induced factor for immunosuppression |
| 09/28/1994 | EP0483237B1 Protection of nk cell cytolytic activity in pbmc |
| 09/28/1994 | EP0372063B1 Human myeloperoxydasis and its therapeutic application |
| 09/28/1994 | CN1092771A Aminomethylene substituted non-aromatic heterocycles |
| 09/28/1994 | CN1092768A Pyrazoles and pyrazolopyrimidines |
| 09/27/1994 | US5350860 Bicyclic compounds |
| 09/27/1994 | US5350574 Immunosuppressive agent for preventing organ rejection |
| 09/27/1994 | CA1332172C 6,11-dihydro-11-(4-piperidylidene)-5h-benzo ¬5,6|cyclohepta-¬1,2-b|pyridines and compositions and methods of use |
| 09/25/1994 | CA2119530A1 Pharmaceutical compounds |
| 09/24/1994 | CA2118831A1 Derivatives of (2-methyl-3-piridyl) cyanomethylpiperazine |
| 09/21/1994 | EP0615969A1 2,4-Diamino-3-hydroxycarboxylic acid derivatives |
| 09/21/1994 | EP0615546A1 Region of cytoplasmic domain of the human interleukin-4 receptor, as antagonists of il-4 |
| 09/21/1994 | EP0371017B1 Antibodies against streptococcus |
| 09/21/1994 | CN1092427A Enantiomerically pure SS-D-dioxolane nucleosides with selective anti-hepatitis B virus activity |
| 09/21/1994 | CN1092409A Compounds for treating leukotriene-related diseases |
| 09/21/1994 | CN1092407A Compounds |
| 09/21/1994 | CN1092406A Compounds |
| 09/20/1994 | US5349061 O-heteroaryl, O-alkylheteroaryl, O-alkenylheteroaryl and O-alkynylheteroarylmacrolides having immunosuppressive activity |
| 09/20/1994 | US5348975 7-chromanyl esters of phenols and benzoic acids having retinoid-like activity |
| 09/20/1994 | US5348952 Antibiotics for antiinflammatory agents, degenerative diseases caused by proteolytic enzymes and respiratory system disorders |
| 09/20/1994 | CA1332057C Bicycloalkyl, tricycloalkyl, azabicycloalkyl and azatricycloalkyl amides |
| 09/15/1994 | WO1994020623A1 Cloning and recombinant production of vespid venom enzymes, such as phospholipase and hyaluronidase, and immunological therapies based thereon |
| 09/15/1994 | WO1994020619A1 LO-CD2a ANTIBODY AND USES THEREOF FOR INHIBITING T-CELL ACTIVATION AND PROLIFERATION |
| 09/15/1994 | WO1994020614A1 Allergenic protein and peptides from house dust mite and uses therefor |
| 09/15/1994 | WO1994020540A1 NON-TOXIC RIBOSOME INACTIVATING PROTEINS (RIPs) WITH TWO CHAINS, PROCESS FOR THE PREPARATION THEREOF AND APPLICATIONS |
| 09/15/1994 | WO1994020532A1 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
| 09/15/1994 | WO1994020527A1 Compositions and methods for the treatment of immunomediated inflammatory disorders |
| 09/15/1994 | WO1994020516A1 New sulfated lyso-ganglioside derivatives |
| 09/15/1994 | WO1994020515A1 New o-sulfated gangliosides and lyso-ganglioside derivatives |
| 09/15/1994 | WO1994020455A1 Styryl derivatives, their preparation and use as pde-iv inhibitors |
| 09/15/1994 | WO1994020142A1 Assays and therapeutic methods based on lymphocyte chemoattractants |
| 09/15/1994 | WO1994020127A1 Hla-a2.1 binding peptides and their uses |
| 09/15/1994 | WO1994020110A1 Use of antiepileptics such as carbamazepine and oxcarbazepine for treating aids-related neural disorders |
| 09/15/1994 | WO1994020108A1 Use of lamotrigine for treating aids-related neural disorders |
| 09/15/1994 | WO1994020107A1 Rejection inhibitor for transplants and il-1 production inhibitor |
| 09/15/1994 | WO1994020103A1 Use of riluzole for treating aids-related neural disorders |
| 09/15/1994 | WO1994020085A1 Methods and compositions for inhibition of angiogenesis |
| 09/15/1994 | WO1994020071A1 Water-in-oil fluid vaccinal emulsions containing a metabolizable oil |
| 09/15/1994 | WO1994017192A3 Lysosomal targeting of immunogens |
| 09/15/1994 | WO1994017091A3 Foldback triplex-forming oligonucleotides |
| 09/15/1994 | CA2654420A1 Cloning and recombinant production of vespid venom enzymes, such as phospholiphase and hyaluronidase, and immunological therapies based thereon |
| 09/15/1994 | CA2511085A1 Lo-cd2a antibody and uses thereof for inhibiting t-cell activation and proliferation |
| 09/15/1994 | CA2157510A1 Hla-a2.1 binding peptides and their uses |
| 09/15/1994 | CA2157359A1 New o-sulfated gangliosides and lyso-ganglioside derivatives |
| 09/15/1994 | CA2157357A1 New sulfated lyso-ganglioside derivatives |
| 09/15/1994 | CA2154573A1 Use of anticonvulsants for the treatment of neuro-sida |
| 09/15/1994 | CA2154571A1 Use of lamotrigine for the treatment of neuro-sida |
| 09/15/1994 | CA2134880A1 Graft rejection inhibitor and il-1 production inhibitor |
| 09/14/1994 | EP0614978A1 Soluble human Fcgamma receptors, method to prepare them, pharmaceutical compositions containing them, their use as drugs and their diagnostic use |
| 09/14/1994 | EP0614899A1 5-Phenyl-pyrrolo-1,4-benzoxazine and thiazine derivatives, process and intermediates for their preparation and pharmaceutical compositions containing them |
| 09/14/1994 | EP0614665A1 Use of beer draff extract for the preparation of oral compositions |
| 09/14/1994 | EP0614457A1 Leukotriene-b 4? derivatives, process for preparing the same and medicaments. |
| 09/14/1994 | EP0614374A1 MURINE MONOCLONAL ANTIBODY (5c8) RECOGNIZES A HUMAN GLYCOPROTEIN ON THE SURFACE OF T-LYMPHOCYTES |
| 09/14/1994 | EP0614369A1 Pharmaceutical dipeptide compositions and methods of use thereof |
| 09/14/1994 | EP0614367A1 Substituted lactose and lactosamine derivatives as cell adhesion inhibitors |
| 09/14/1994 | EP0614365A1 Use of a known chemical compound for the production of a pharmaceutical composition for topical application |
| 09/14/1994 | EP0614357A1 Immunopotentiatory agents |
| 09/14/1994 | EP0566592B1 Pyrimido-benzothiazines with lipoxygenase inhibitory action |
| 09/14/1994 | CN1092074A Diazepine derivatives |
| 09/14/1994 | CN1092072A Pharmaceutical compounds |
| 09/14/1994 | CN1092059A Substituted benzoic acids |
| 09/13/1994 | US5347036 Substituted di-t-butylphenols |
| 09/13/1994 | CA2118876A1 2,4-diamino-3-hydroxycarboxylic acid derivatives |
| 09/10/1994 | CA2118558A1 Soluble human fc-gamma iii receptors, process for the preparation thereof, pharmaceutical compositions containing same, utilization thereof as medicaments, and diagnostic application thereof |
| 09/07/1994 | EP0613944A2 Methods for regulating the immune response using CTLA4-binding molecules and IL4-binding molecules |
| 09/07/1994 | EP0613901A2 Macrocyclic immunomodulators |
| 09/07/1994 | EP0613897A1 Piperidine derivatives with antihistaminic and antileukotriene activity |
| 09/07/1994 | EP0613499A1 Human il-4 mutant proteins |
| 09/07/1994 | EP0613468A1 Novel substituted salicyclic acids |
| 09/07/1994 | EP0613463A1 Derivatives of cyclic phenolic thioethers as inhibitors or stimulators of superoxide generation |
| 09/07/1994 | EP0613458A1 Acyclic ethylenediamine derivatives as substance p receptor antagonists |
| 09/07/1994 | EP0613375A1 Pharmaceutical lysine-containing polypeptide compositions and methods of use thereof |
| 09/07/1994 | EP0478609B1 Srif-related peptides and uses thereof |
| 09/07/1994 | CN1091745A Anti-proliferative and anti-inflammatory compounds: derivatives of pentose monosaccharides |
| 09/06/1994 | US5344925 Imidazolidyl macrolides having immunosuppressive activity |
| 09/06/1994 | US5344915 Proteins and the preparation thereof |
| 09/06/1994 | US5344845 Methyl 4(4-acetoxy-3-methoxycinnamanide and salts as an immunosuppressive drug for allergic reactions |
| 09/06/1994 | US5344833 Oxepane isomers of rapamycin useful as immunosuppressive agents |
| 09/06/1994 | US5344828 Piperazinealkanoic acid and a pharmaceutical composition comprising the same |
| 09/06/1994 | US5344774 Human intracisternal A-type retroviral particles associated with sjogren's syndrome |
| 09/01/1994 | WO1994019470A1 Soluble t-cell receptor alpha chain and derivatives used as prophylactic and therapeutic agents for autoimmune diseases |
| 09/01/1994 | WO1994019325A1 Coupling product obtained from hystamine and an amino acid |
| 09/01/1994 | WO1994019321A1 Inhibitors of hiv reverse transcriptase |
| 09/01/1994 | WO1994019015A1 Recombinant fowlpox viruses and uses thereof |
| 09/01/1994 | WO1994019014A1 Recombinant fowlpox virus s-fpv-043 and uses thereof |
| 09/01/1994 | WO1994019011A1 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis b virus |
| 09/01/1994 | WO1994018999A1 A mutant protein and methods and materials for making and using it |
| 09/01/1994 | CA2156735A1 Pharmaceutical compositions for the treatment of inflammatory or immunological diseases and a method for the treatment of said diseases |
| 09/01/1994 | CA2156423A1 Recombinant fowlpox viruses and uses thereof |
| 09/01/1994 | CA2156420A1 Inhibitors of hiv reverse transcriptase |
| 08/31/1994 | EP0612733A1 Use of Phthaloylhydrazide Derivatives as Anti-Hypoxic and defensive Agents |
| 08/31/1994 | EP0612321A1 Pyrido pyridazinone and pyridazinthione compounds with pde iv inhibiting activity |
| 08/31/1994 | EP0561882B1 Hydroxamic acid derivatives which inhibit lipoxygenase |
| 08/31/1994 | EP0505413B1 Beta-lactam derivatives |
| 08/31/1994 | CN1091316A Method and composition for the treatment |
| 08/31/1994 | CN1025786C Carbamoyl derivatives |